PHARMACOTHERAPY OF HEART FAILURE: A NARRATIVE REVIEW OF CONTEMPORARY GUIDELINE-DIRECTED DRUG THERAPY
ACUMEN: INTERNATIONAL JOURNAL OF MULTIDISCIPLINARY RESEARCH · 2026
DOI: 10.66301/0zd1a866 ↗Kurz gefasst
Leitlinie in der Zeitschrift ACUMEN: INTERNATIONAL JOURNAL OF MULTIDISCIPLINARY RESEARCH, 2026. Verfasst von Dr Prince sharma und 2 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Herzinsuffizienz
Abstract (Originalsprache)
Heart failure remains one of the most common, costly, and lethal cardiovascular syndromes worldwide, affecting more than 64 million people globally and carrying a prognosis that is often worse than many forms of cancer. Over the past four decades, pharmacological management has evolved from a purely symptomatic, diuretic centred approach into a sophisticated, evidence-driven strategy that targets the neurohormonal maladaptation underlying the disease. This narrative review summarizes the pharmacotherapy of heart failure with a focus on guideline-directed medical therapy (GDMT) for heart failure with reduced ejection fraction (HFrEF).
Zitieren
APA
sharma, D. P., Chaudhary, D. M., & payak, D. D. (2026). PHARMACOTHERAPY OF HEART FAILURE: A NARRATIVE REVIEW OF CONTEMPORARY GUIDELINE-DIRECTED DRUG THERAPY. ACUMEN: INTERNATIONAL JOURNAL OF MULTIDISCIPLINARY RESEARCH. https://doi.org/10.66301/0zd1a866
Vancouver
sharma DP, Chaudhary DM, payak DD. PHARMACOTHERAPY OF HEART FAILURE: A NARRATIVE REVIEW OF CONTEMPORARY GUIDELINE-DIRECTED DRUG THERAPY. ACUMEN: INTERNATIONAL JOURNAL OF MULTIDISCIPLINARY RESEARCH. 2026. doi:10.66301/0zd1a866
BibTeX
@article{sharma2026,
author = {sharma, Dr Prince and Chaudhary, Dr Mohit and payak, Dr Divyanshu},
title = {PHARMACOTHERAPY OF HEART FAILURE: A NARRATIVE REVIEW OF CONTEMPORARY GUIDELINE-DIRECTED DRUG THERAPY},
journal = {ACUMEN: INTERNATIONAL JOURNAL OF MULTIDISCIPLINARY RESEARCH},
year = {2026},
doi = {10.66301/0zd1a866}
}
EUVIMED